Albany, NY -- (SBWIRE) -- 12/14/2017 -- "However, a raft of medical device manufacturers are expected to foray into the global market, which is likely to alter the current dynamics and intensify the competition over the coming years," says TMR's lead analyst. The global market for pain management devices is anticipated to reach a valuation of US$6.3 bn by 2023, progressing at a CAGR of 7.60% between 2015 and 2023.

Read Report Overview @ https://www.transparencymarketresearch.com/pain-management-drugs-devices.html

The Global Pain Management Devices Market is segmented on the basis of Product Type, Application and Region.

Based on product, the neurostimulation devices segment will continue to be the leading revenue contributor until 2023. The commercialization of pathbreaking technologies related to neurostimulation and widening pool of patients suffering from chronic pain such as cancer and musculoskeletal pain are fuelling the dominance of the segment. On the other hand, the analgesic infusion pumps segment will exhibit a significant CAGR of 10.3% during the review period.

Geographically, North America will continue to lead the market until 2023, accounting for 48.7% of the overall market revenue. The increasing incidence of sports-related injuries and presence of advanced healthcare infrastructure are translating into the greater uptake of pain management devices in the region. Asia Pacific is estimated to be the most promising region, owing to the mounting cases of diabetes and chronic wounds.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1143

Summary of Table of Content

1 Preface
2 Executive Summary
3 Pain Management Devices Market Overview
4 Market Segmentation – By Product Type
5 Market Segmentation - By Application
6 Market Segmentation - By Region
7 Recommendations
8 Company Profiles

Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/1143